Search Results

Return to List
Results 1–20 of 93
Sort By: Relevance | Date | Title

Antenatal Corticosteroid Therapy for Fetal Maturation

Committee Opinion Number 677, October 2016

ABSTRACT Corticosteroid administration before anticipated preterm birth is one of the most important antenatal therapies available to improve newborn outcomes A single course of corticosteroids is recommended for pregnant women between 24 07 weeks and 33 67 weeks of gestation including for those w...

October 2016

PDF Format

Immediate Postpartum Long-Acting Reversible Contraception

Committee Opinion Number 670, August 2016

ABSTRACT Immediate postpartum longacting reversible contraception LARC has the potential to reduce unintended and shortinterval pregnancy Women should be counseled about all forms of postpartum contraception in a context that allows informed decision making Immediate postpartum LARC should be offe...

August 2016

PDF Format

Hospital-Based Triage of Obstetric Patients

Committee Opinion Number 667, July 2016

ABSTRACT Emergency departments typically have structured triage guidelines for health care providers encountering the diverse cases that may present to their units Such guidelines aid in determining which patients must be evaluated promptly and which may wait safely and aid in determining anticipa...

July 2016

PDF Format

Optimizing Postpartum Care

Committee Opinion Number 666, June 2016

ABSTRACT In the weeks after birth postpartum care often is fragmented among maternal and pediatric health care providers and communication between inpatient and outpatient settings is inconsistent To optimize postpartum care anticipatory guidance should begin during pregnancy During antenatal care...

June 2016

PDF Format

Refusal of Medically Recommended Treatment During Pregnancy

Committee Opinion Number 664, June 2016

(Replaces Committee Opinion Number 321, November 2005)

ABSTRACT One of the most challenging scenarios in obstetric care occurs when a pregnant patient refuses recommended medical treatment that aims to support her wellbeing her fetuss wellbeing or both In such circumstances the obstetriciangynecologists ethical obligation to safeguard the pregnant wom...

June 2016

PDF Format

Integrating Immunizations Into Practice

Committee Opinion Number 661, April 2016

ABSTRACT Immunization against vaccinepreventable diseases is an essential component of womens primary and preventive health care Despite the importance of vaccination and clear guidance from public health agencies rates of vaccination lag behind national goals Obstetriciangynecologists can play a ...

April 2016

PDF Format

Family Building Through Gestational Surrogacy

Committee Opinion Number 660, March 2016

(Replaces Committee Opinion No. 397, February 2008)

ABSTRACT Gestational surrogacy is an increasingly common form of family building that can allow individuals or a couple to become parents despite circumstances in which carrying a pregnancy is biologically impossible or medically contraindicated The practice of gestational surrogacy involves a wom...

March 2016

PDF Format

Guidelines for Diagnostic Imaging During Pregnancy and Lactation

Committee Opinion Number 656, February 2016

(Replaces Committee Opinion Number 299, September 2004)

ABSTRACT Imaging studies are important adjuncts in the diagnostic evaluation of acute and chronic conditions However confusion about the safety of these modalities for pregnant and lactating women and their infants often results in unnecessary avoidance of useful diagnostic tests or the unnecessar...

February 2016

PDF Format

Magnesium Sulfate Use in Obstetrics

Committee Opinion Number 652, January 2016

(Reaffirmed 2016. Replaces Committee Opinion Number 573, September 2013)

ABSTRACT The US Food and Drug Administration advises against the use of magnesium sulfate injections for more than 57 days to stop preterm labor in pregnant women Based on this the drug classification was changed from Category A to Category D and the labeling was changed to include this new warnin...

January 2016

PDF Format

Physical Activity and Exercise During Pregnancy and the Postpartum Period

Committee Opinion Number 650, December 2015

(Replaces Committee Opinion Number 267, January 2002)

ABSTRACT Physical activity in all stages of life maintains and improves cardiorespiratory fitness reduces the risk of obesity and associated comorbidities and results in greater longevity Physical activity in pregnancy has minimal risks and has been shown to benefit most women although some modifi...

December 2015

PDF Format

Umbilical Cord Blood Banking

Committee Opinion Number 648, December 2015

(Replaces Committee Opinion Number 399, February 2008)

ABSTRACT Once considered a waste product that was discarded with the placenta umbilical cord blood is now known to contain potentially lifesaving hematopoietic stem cells When used in hematopoietic stem cell transplantation umbilical cord blood offers several distinct advantages over bone marrow o...

December 2015

PDF Format

Dual Therapy for Gonococcal Infections

Committee Opinion Number 645, November 2015

ABSTRACT Gonorrhea is the second most commonly reported bacterial sexually transmitted disease in the United States with an estimated 820000 new Neisseria gonorrhoeae infections occurring each year Antimicrobial resistance limits treatment success heightens the risk of complications and may facili...

November 2015

PDF Format

The Apgar Score

Committee Opinion Number 644, October 2015

(Replaces Committee Opinion Number 333, May 2006)

ABSTRACT The Apgar score provides an accepted and convenient method for reporting the status of the newborn infant immediately after birth and the response to resuscitation if needed The Apgar score alone cannot be considered to be evidence of or a consequence of asphyxia does not predict individu...

October 2015

PDF Format

Identification and Referral of Maternal Genetic Conditions in Pregnancy

Committee Opinion Number 643, October 2015

ABSTRACT Advances in the understanding of genetic conditions reproductive technologies and improved medical and surgical care have enabled an increasing number of women with genetic conditions to achieve a normal pregnancy outcome However management of certain genetic conditions during pregnancy i...

October 2015

PDF Format

Cell-free DNA Screening for Fetal Aneuploidy

Committee Opinion Number 640, September 2015

(This Committee Opinion Replaces Committee Opinion Number 545)

ABSTRACT Noninvasive prenatal screening that uses cellfree DNA from the plasma of pregnant women offers tremendous potential as a screening method for fetal aneuploidy A number of laboratories have validated different techniques for the use of cellfree DNA as a screening test for fetal aneuploidy ...

September 2015

PDF Format

The Importance of Vital Records and Statistics for the Obstetrician-Gynecologist

Committee Opinion Number 639, September 2015

ABSTRACT Information from vital records is critical to identify and quantify healthrelated issues and to measure progress toward quality improvement and public health goals In particular maternal and infant mortality serve as important indicators of the nations health thereby influencing policy de...

September 2015

PDF Format

First-Trimester Risk Assessment for Early-Onset Preeclampsia

Committee Opinion Number 638, September 2015

ABSTRACT Hypertensive disorders with adverse sequelae including preterm birth maternal morbidity and mortality and longterm risk of maternal cardiovascular disease complicate 510 of pregnancies Early identification of pregnant women at risk of developing earlyonset preeclampsia would theoretically...

September 2015

PDF Format

Marijuana Use During Pregnancy and Lactation

Committee Opinion Number 637, July 2015

ABSTRACT Cannabis sativa marijuana is the illicit drug most commonly used during pregnancy The selfreported prevalence of marijuana use during pregnancy ranges from 2 to 5 in most studies A growing number of states are legalizing marijuana for medicinal or recreational purposes and its use by preg...

July 2015

PDF Format

Management of Women With Phenylketonuria

Committee Opinion Number 636, June 2015

(Replaces Committee Opinion Number 449, December 2009)

ABSTRACT Phenylketonuria PKU is an autosomal recessive disorder of phenylalanine Phe metabolism characterized by deficient activity of the hepatic enzyme phenylalanine hydroxylase Increased blood Phe levels are toxic to a variety of tissues particularly the developing fetal brain The mainstay of t...

June 2015

PDF Format

Prenatal and Perinatal Human Immunodeficiency Virus Testing - Expanded Recommendations

Committee Opinion Number 635, June 2015

(Replaces Committee Opinion Number 418, September 2008)

ABSTRACT Given the enormous advances in the prevention of perinatal transmission of human immunodeficiency virus HIV it is clear that early identification and treatment of all pregnant women with HIV is the best way to prevent neonatal infection and also improve womens health Furthermore new evide...

June 2015

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998